 |
인쇄하기
취소
|
Clearing US biosimilar pathway hurdles is expected to be an arduous exercise
Biosimilar development is riddled with complexities, ranging from regulatory, to manufacturing to marketing, and is one of the most expensive propositions in the pharmaceutical industry.
On March 23, 2010, President Obama signed into law healthcare reform legislation known as the “Patient Protection and Affordable Care Act.” The legislation contains provisions that will establish, for the fi...
On March 23, 2010, President Obama signed into law healthcare reform legislation known as the “Patient Protection and Affordable Care Act.” The legislation contains provisions that will establish, for the fi...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.